Medical Technology

New Zealand Says Man’s Death Could be connected to Pfizer Vaccine

New Zealand health officials believe that a man aged 26’s death could be linked to the COVID-19 vaccine made by Pfizer.

The man passed away two weeks after receiving his first dose of vaccine according to Bloomberg News reporting. A quick review indicates that the likely cause of death was myocarditis which is a rare adverse reaction to the vaccine that causes inflammation of the wall of the heart muscle.

“The Board has concluded that myocarditis might be the result of vaccination,” New Zealand’s COVID-19 Vaccine Independent Safety Monitoring Board made an announcement to Bloomberg Monday.

According to the board, “COVID-19 infection can cause myocarditis and other serious diseases.” It is safer to get vaccinated than to get infected.

The man’s death marks the second death in New Zealand that may be linked to COVID-19 vaccines, Bloomberg reported. A woman died in the late August of myocarditis. The board said it was likely caused by vaccination. Two other individuals — a 13-year-old child and an elderly man — have also died with potential myocarditis, though they could not be caused by vaccination.

Bloomberg was informed by the board that the benefits of vaccination with the Pfizer COVID-19 vaccine continue outweigh the risks.

According to an update in November from the World Health Organization, myocarditis “very rare” but has been documented since the introduction of the Moderna and Pfizer vaccines. The majority of cases occur in young men between 16 to 24 years old following receiving the second dose of vaccine. Usually, the cases occur within several days.

“Available evidence suggests that myocarditis as well as pericarditis after vaccination are typically mild and respond well to conservative treatment and are more likely to be successful than classic myocarditis, COVID-19 or COVID-19,” stated the WHO. “The risk of developing myocarditis due to SARS-CoV-2 is higher than the risk that is associated with vaccination.”

According to a mid November update from CDC the public health agency is monitoring reports of myocarditis. The majority of patients who received treatment for myocarditis responded well to medicine and rest, according to the federal agency.

It stated that the CDC recommends that all children aged 5 and over get immunized against COVID-19. “The risks of COVID-19 and the associated potential serious complications like hospitalization, long-term illness or even death, are far greater than the potential risks of having an uncommon adverse reaction, such as myocarditis and the pericarditis.

Content Source:

The Medical Progress

The Medical Progress is here to provide news for the medical industry on a daily basis which are mainly on the medical cannabis and it’s legalisation.

Related Articles